A team of researchers from the University of California San Diego School of Medicine have developed a new RNA-oriented gene editing technique which could treat hereditary diseases such as ALS and Huntington’s. The team used a method called RNA-targeting CAS9 (RCas9) to track RNA in live cells and correct “molecular mistakes” which lead to diseases…
Continue reading…
New gene editing technique could treat ALS and Huntington’s.
Posted on Leave a comment
SA signs innovation agreement with Novartis
Posted on Leave a comment
A high-level memorandum of understanding (MoU) for medical research and development has been signed between the South African Medical Research Council (SAMRC), the department of science and technology (DST) and Swiss drug firm, Novartis. The MoU, a public private partnership (PPP), aims to establish a framework for potential cooperation between the parties. This will allow..
Continue reading…